Literature DB >> 10502774

RB1 gene mutations in retinoblastoma.

D R Lohmann1.   

Abstract

Mutations in both alleles of the RB1 gene are causal for the development of retinoblastoma, a childhood tumor of the eye. The spectrum of somatic and germline mutations in this gene is dominated by small mutations. Data on small mutations are listed in a locus specific database available at http://www.d-lohmann.de/Rb/mutations.html. Analysis of 368 reported small mutations reveals considerable heterogeneity. A notable recurrence of transitions is observed at 13 CpG-dinucleotides that are part of CGA codons or splice donor sites. Most mutations create a premature termination codon. With few exceptions, patients heterozygous for mutations of this kind develop bilateral retinoblastoma. Missense mutations and inframe deletions are rare. Some of these mutations are associated with a distinct phenotype marked by incomplete penetrance and reduced expressivity. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10502774     DOI: 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  47 in total

1.  Ethnic variations of a retinoblastoma susceptibility gene (RB1) polymorphism in eight Asian populations.

Authors:  Priya Kadam-Pai; Xin-Yi Su; Jasmin Jiji Miranda; Agustinus Soemantri; Nilmani Saha; Chew-Kiat Heng; Poh-San Lai
Journal:  J Genet       Date:  2003 Apr-Aug       Impact factor: 1.166

2.  Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.

Authors:  Elke Pfaff; Christian Aichmüller; Martin Sill; Damian Stichel; Matija Snuderl; Matthias A Karajannis; Martin U Schuhmann; Jens Schittenhelm; Martin Hasselblatt; Christian Thomas; Andrey Korshunov; Marina Rhizova; Andrea Wittmann; Anna Kaufhold; Murat Iskar; Petra Ketteler; Dietmar Lohmann; Brent A Orr; David W Ellison; Katja von Hoff; Martin Mynarek; Stefan Rutkowski; Felix Sahm; Andreas von Deimling; Peter Lichter; Marcel Kool; Marc Zapatka; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2019-11-25       Impact factor: 17.088

3.  Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma.

Authors:  David Creytens; Joost van Gorp; Suvi Savola; Liesbeth Ferdinande; Thomas Mentzel; Louis Libbrecht
Journal:  Virchows Arch       Date:  2014-07       Impact factor: 4.064

4.  Molecular nature of 11 spontaneous de novo mutations in Drosophila melanogaster.

Authors:  H P Yang; A Y Tanikawa; A S Kondrashov
Journal:  Genetics       Date:  2001-03       Impact factor: 4.562

Review 5.  Models of carcinogenesis: an overview.

Authors:  Paolo Vineis; Arthur Schatzkin; John D Potter
Journal:  Carcinogenesis       Date:  2010-04-29       Impact factor: 4.944

6.  Mainstreaming genetic testing of cancer predisposition genes.

Authors:  Nazneen Rahman
Journal:  Clin Med (Lond)       Date:  2014-08       Impact factor: 2.659

7.  A cancer derived mutation in the retinoblastoma gene with a distinct defect for LXCXE dependent interactions.

Authors:  Shauna A Henley; Sarah M Francis; Jordan Demone; Peter Ainsworth; Frederick A Dick
Journal:  Cancer Cell Int       Date:  2010-03-18       Impact factor: 5.722

8.  Paradoxical instability-activity relationship defines a novel regulatory pathway for retinoblastoma proteins.

Authors:  Pankaj Acharya; Nitin Raj; Martin S Buckley; Liang Zhang; Stephanie Duperon; Geoffrey Williams; R William Henry; David N Arnosti
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

9.  RB1 germ-line deletions in Argentine retinoblastoma patients.

Authors:  Cecilia Fernández; Karina Repetto; Viviana Dalamon; Fenanda Bergonzi; Veronica Ferreiro; Irene Szijan
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

10.  Disruption of chromosome 11 in canine fibrosarcomas highlights an unusual variability of CDKN2B in dogs.

Authors:  Jesús Aguirre-Hernández; Bruce S Milne; Chris Queen; Patricia C M O'Brien; Tess Hoather; Sean Haugland; Malcolm A Ferguson-Smith; Jane M Dobson; David R Sargan
Journal:  BMC Vet Res       Date:  2009-07-31       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.